Sangamo Therapeutics IncEigentümerstruktur
| Preis (2026-07-02) | 52W Hoch | 52W Tief |
| 0.074 USD | 0,766 USD | 0,064 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 1,5 USD | 3 | 2 | 2 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 414.288.847 | 10,42 | 5,55 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Sangamo Therapeutics Inc
Mitarbeiter 142
Handelsplatz NASDAQ
Ticker Symbol SGMO
IPO Datum 2000-04-06
Adresse 501 Canal Blvd, Richmond, CA, United States, 94804
Webseite https://www.sangamo.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Alexander D. Macrae Ch.B, M.B., MRCP, Ph.D. | CEO, President & Director |
| 2 | Mr. Scott B. Willoughby | Senior VP, Chief Legal Officer & Corporate Secretary |
| 3 | Dr. Nathalie Dubois-Stringfellow Ph.D. | Senior VP & Chief Development Officer |
| 4 | Mr. Nikunj Jain | Interim CFO and Principal Financial & Accounting Officer |
| 5 | Dr. Gregory Davis Ph.D. | Head of Research & Technology |
| 6 | Ms. Louise Wilkie | Head of Global Corporate Communications & Investor Relations |
| 7 | Mr. Phillip Ramsey | Chief Technical Officer |
| 8 | Ms. Stephanie J. Seiler CLP | VP and Head of Business Development & Alliance Management |
| 9 | Mr. David Ojala | Scientist II - Discovery & Translational Research |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | Armistice Capital, LLC | 0,00% | 0,00 Mio. USD |
| 2 | Vanguard Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 3 | Vanguard Group Inc | 0,00% | 0,00 Mio. USD |
| 4 | Two Sigma Investments LLC | 0,00% | 0,00 Mio. USD |
| 5 | Balyasny Asset Management LLC | 0,00% | 0,00 Mio. USD |
| 6 | Geode Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 7 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 8 | Two Sigma Advisers, LLC | 0,00% | 0,00 Mio. USD |
| 9 | Renaissance Technologies Corp | 0,00% | 0,00 Mio. USD |
| 10 | UBS Group AG | 0,00% | 0,00 Mio. USD |
| 11 | Charles Schwab Investment Management Inc | 0,00% | 0,00 Mio. USD |
| 12 | Vanguard Fiduciary Trust Co | 0,00% | 0,00 Mio. USD |
| 13 | Jacobs Levy Equity Management, Inc. | 0,00% | 0,00 Mio. USD |
| 14 | Bank of America Corp | 0,00% | 0,00 Mio. USD |
| 15 | State Street Corp | 0,00% | 0,00 Mio. USD |
| 16 | Susquehanna International Group, LLP | 0,00% | 0,00 Mio. USD |
| 17 | Luminus Management, LLC | 0,00% | 0,00 Mio. USD |
| 18 | Ikarian Capital, LLC | 0,00% | 0,00 Mio. USD |
| 19 | Amvescap Plc. | 0,00% | 0,00 Mio. USD |
| 20 | Oracle Investment Management Inc | 0,00% | 0,00 Mio. USD |